Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03214510Phase 3Active, not recruiting
A Phase 3 trial of bupivacaine, liposomal bupivacaine, fentanyl, hydromorphone in postoperative pain, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2017; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03214510.